Concept information
...
Nitrogen and nitrogen compound product
Product containing crisaborole (medicinal product)
Crisaborole in cutaneous dosage form
Product containing only crisaborole in cutaneous dose form (medicinal product form)
...
Ether structure-containing product
Product containing crisaborole (medicinal product)
Crisaborole in cutaneous dosage form
Product containing only crisaborole in cutaneous dose form (medicinal product form)
...
Phosphodiesterase 4 inhibitor
Product containing crisaborole (medicinal product)
Crisaborole in cutaneous dosage form
Product containing only crisaborole in cutaneous dose form (medicinal product form)
...
Medicinal product (product)
Product manufactured as cutaneous dosage form
Crisaborole in cutaneous dosage form
Product containing only crisaborole in cutaneous dose form (medicinal product form)
...
Nitrogen and nitrogen compound product
Product containing crisaborole (medicinal product)
Product containing only crisaborole (medicinal product)
Product containing only crisaborole in cutaneous dose form (medicinal product form)
Preferred term
Crisaborole 20 mg/g cutaneous ointment
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Has basis of strength substance
Has concentration strength denominator unit
Has concentration strength numerator unit
Has manufactured dose form
Has precise active ingredient
In other languages
URI
http://www.irandoc.acir/onto/irandoc/1010543004
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}